1. Search Result
Search Result
Results for "

active immunization

" in MedChemExpress (MCE) Product Catalog:

8

Inhibitors & Agonists

1

Biochemical Assay Reagents

15

Peptides

Cat. No. Product Name Target Research Area
  • HY-P2006

    Peptides Others
    Abecomotide is a biological active peptide. (an immunological agent for active immunization)
  • HY-P10022

    hTERT (651-665)

    Peptides Cancer
    Riletamotide is an immunological agent for active immunization .
  • HY-P5539

    Peptides Cancer
    Omramotide is an immunological agent for active immunization (antineoplastic) .
  • HY-P5540

    Biochemical Assay Reagents Cancer
    Oximbomotide is an immunological agent for active immunization (antineoplastic) .
  • HY-P5541

    Peptides Cancer
    Sucantomotide is an immunological agent for active immunization (antineoplastic) .
  • HY-P4151

    Peptides Inflammation/Immunology Cancer
    Marlumotide is an immunological agent for active immunization, as well as an antineoplastic agent .
  • HY-P5534

    UCP2

    Peptides Cancer
    Enavermotide (UCP2) is an immunological agent for active immunization (antineoplastic) .
  • HY-P4148

    Peptides Inflammation/Immunology Cancer
    Vorumotide is an immunological agent for active immunization as well as an antineoplastic agent .
  • HY-P4152

    Peptides Inflammation/Immunology Cancer
    Etimumotide is an immunological agent for active immunization, as well as an antineoplastic agent .
  • HY-P10021

    hTERT (691–705)

    Peptides Inflammation/Immunology
    Tapderimotide (hTERT (691–705)) is an immunological agent for active immunization .
  • HY-P4149

    IDO194-214

    Indoleamine 2,3-Dioxygenase (IDO) Inflammation/Immunology Cancer
    Imsamotide (IDO194-214) is a Indoleamine 2,3-Dioxygenase (IDO) peptide with sequences of DTLLKALLEIASCLEKALQVF, the IDO194-214. Imsamotide is also an immunological agent for active immunization, as well as an antineoplastic agent .
  • HY-P4145

    Peptides Inflammation/Immunology Cancer
    Quazomotide is a WT1 class II peptide epitope with sequences of RSDELVRHHNMHQRNMTKL. Quazomotide stimulates a peptide-specific CD4(+) response, to recognize WT1(+) tumor cells. Quazomotide is an immunological agent for active immunization, as well as an antineoplastic agent .
  • HY-P5912

    iGluR Neurological Disease
    GluN1 (356-385) is an antigenic peptide against N-methyl-D-aspartate receptor (NMDAR) encephalitis. GluN1 (356-385) has the effect of reducing the density of surface NMDAR clusters in hippocampal neurons. GluN1 (356-385) can be used to study the pathogenesis of anti-NMDAR encephalitis .
  • HY-P5396A

    Amino Acid Decarboxylase Others
    GAD65 (524-543) acetate is a biological active peptide with amino acids 524 to 543 fragment of glutamic acid decarboxylase 65 (GAD65). GAD65 (524-543) acetate is one of the first fragments of the islet antigen to induce proliferative T cell responses in the non-obese diabetic (NOD) mouse model of spontaneous autoimmune diabetes. GAD65 (524-543) acetate is a specific, possibly low affinity, stimulus for the spontaneously arising diabetogenic T cell clone BDC2.5. Immunization with GAD65 (524-543) acetate increases the susceptibility of the NOD mice to type 1 diabetes induced by the adoptive transfer of BDC2.5 T cells .
  • HY-P5396

    Amino Acid Decarboxylase Others
    GAD65 (524-543) is a biological active peptide with amino acids 524 to 543 fragment of glutamic acid decarboxylase 65 (GAD65). GAD65 (524-543) is one of the first fragments of islet antigen to induce proliferative T cell responses in the non-obese diabetic (NOD) mouse model of spontaneous autoimmune diabetes. GAD65 (524-543) is a specific, possibly low affinity, stimulus for the spontaneously arising diabetogenic T cell clone BDC2.5. Immunization with GAD65 (524-543) increases the susceptibility of the NOD mice to type 1 diabetes induced by the adoptive transfer of BDC2.5 T cells .

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: